Industry Focus
Healthcare: Is Valeant Pharmaceuticals the Turnaround Story of the Century?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:24:09
- Mas informaciones
Informações:
Sinopsis
The much-maligned company is making progress on its restructuring plan, but it's not out of the woods yet. Plus, why Keryx Pharmaceuticals shares tumbled despite winning an FDA approval that more than doubles its addressable market.
